Rupesh Parikh, Oppenheimer managing director and senior analyst, joins 'Squawk Box' to break down Walmart's quarterly ...

As NVIDIA increases the output of its next-generation Blackwell architecture, its AI hardwareespecially its H200 GPUsis ...

Fintel reports that on February 24, 2025, Oppenheimer upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from ...

Two Indiana Pacers fans have sued the Milwaukee Bucks and Patrick Beverley after the point guard threw a ball into the stands ...

The tax rate would be $25,000 per foot of height. Ehlers said Monday that the average windmill height would amount to ...

Only 9,945 Tesla EVs were registered in Europe, down from 18,161 a year ago in January, per the European Automobile ...

Efforts are ongoing to rehabilitate the Oppenheimer Beach Facility on the island of St. John thanks to a $1 million grant ...

Despite doubts about the immensely talented RDJ's suitability to play Doctor Doom, these past roles prove he'll be great.

Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.

Oppenheimer upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a market perform rating to an outperform rating in a research note published on Monday morning, MarketBeat ...

Oppenheimer upgraded BioMarin (BMRN) to Outperform from Perform with a $98 price target BioMarin reported strong Q4 results and Oppenheimer ...